Navigation Links
Schering-Plough Reports Financial Results for First Quarter of 2008
Date:4/23/2008

48%

REMICADE 507 373 36%

NASONEX 307 284 8%

TEMODAR 236 196 20%

PEGINTRON 225 217 4%

CLARINEX / AERIUS 213 204 4%

FOLLISTIM/PUREGON c/ 145 - N/M

AVELOX 142 115 24%

CLARITIN RX 128 112 14%

NUVARING c/ 96 - N/M

INTEGRILIN 74 84 (13%)

CAELYX 74 62 20%

REMERON c/ 68 - N/M

ZEMURON c/ 63 - N/M

REBETOL 59 71 (17%)

INTRON A 55 60 (8%)

SUBUTEX / SUBOXONE 54 56 (4%)

PROVENTIL / ALBUTEROL CFC 50 53 (5%)

ELOCON 45 36 23%

LIVIAL c/ 45 - N/M

CERAZETTE c/ 44 - N/M

MERCILON c/ 43 - N/M

ASMANEX 42 43 (1%)

IMPLANON c/ 38 - N/M

MARVELON c/ 37 - N/M

NOXAFIL 34 16 115%

FORADIL
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
2. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
3. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
6. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
7. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
8. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
11. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...ge of Wisconsin has promoted William Hendee to pr... ,T. Michael Bolger, the college,s president and C...t 14 years, Bill Hendee has provided outstanding l...e of Wisconsin: biomedical research, technology tr...te School of Biomedical Sciences," Bolger said. , ...
...no-geography of other states across the Midwest, a...at,s not a psychiatric diagnosis, but instead a re...ave one or more tech centers. , ,Minnesota has th... University of Minnesota) and the Mayo Clinic in R...University and a number of research labs, and the ...
...chnologies Inc. reported a loss of $4.4 million o...ded March 31, attributing the shortfall to the tim...agents. , ,Third Wave makes clinical molecular dia... of infectious diseases and cystic fibrosis, a gen... company earned $2.8 million on revenues of $15.3 ...
...rivilege of moderating a thought-provoking roundta...er-increasing mobile work force. Hosted by IP-tele...r academics, market analysts, communications, IT e...ny one conclusion from the two-hour session, it wa...nected work- and lifestyle is driving a massive bu...
Other Biology Technology:Having two biomedical tech centers in Wisconsin will help the state 2Having two biomedical tech centers in Wisconsin will help the state 3Most of us still struggle with mobility 2Most of us still struggle with mobility 3Most of us still struggle with mobility 4
(Date:10/3/2008)...h. The United States lacks the standards to ensur...se environmental harm, says a distinguished group ...try is so young, policymakers have an exceptional ...e the industry doesn,t harm the environment. , "... industry moves out of its research and developmen...
(Date:10/3/2008)... Aluminum toxicity, a global agricultural problem...gricultural productivity for more than half of the...ts have puzzled over how toxic levels of aluminum ... is that aluminum binds to several targets in the ... and ultimately interrupting plant growth. , Now...
(Date:10/3/2008)...CTOBER 2008 - More than 8,000 international scient...ention Center to participate in the first-ever Joi...ct. 5-9. A major part of their focus will be agric... research responses to major agricultural challeng...Brown Convention Center, Houston, TX , Contact:...
(Date:10/3/2008)...Y, October 3, 2008Novel platform technologies and ...evelopment of molecular diagnostics, reports Gene... payoff for successful molecular diagnostic produc...icts that this market currently exceeds $3.2 billi...ears, according to an article in the October 1 iss...
Breaking Biology News(10 mins):Experts agree: Environmental standards needed for biofuels 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 2UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants 3Agricultural research highlighted in Houston 2Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2Bionovo to Present at A G Edwards 2nd Annual Emerging Growth Conference 2007 522 1Bionovo to Present at A G Edwards 2nd Annual Emerging Growth Conference 2007 522 2Genstruct CEO Dr Keith Elliston Invited to Speak at Oncology Clinical Trial Summit 517 1Genstruct CEO Dr Keith Elliston Invited to Speak at Oncology Clinical Trial Summit 517 2Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 1Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 2Manic phase of bipolar disorder benefits from breast cancer medication 1070 1Manic phase of bipolar disorder benefits from breast cancer medication 1070 2Manic phase of bipolar disorder benefits from breast cancer medication 1070 3
...nd transmit information via special contact sites ...rmining what we remember and what we forget. When ...aracteristics of these contact sites change. Scien...ecular processes which cause that change. , Resea...stitute for Developmental Biology in Tübingen (no...
...g believed that bigger is better when it comes to ...rses to dinosaurs, have evolved into larger specie... two biologists at the University of California, S...ings of the National Academy of Sciences suggests ...rtly true. , The scientists found that populatio...
...es fly the coop to hunt for a new home, usually a ... which site is right: With great efficiency they n...sions. , Their technique, says Cornell University...ing until a quorum develops. , The Seeley group,s...f American Scientist, might well be used to help i...
...ng wondered how nuclear pores ?the all-important c...d out of a cell,s nucleus ?double in number to pre...w, for the first time, scientists at the Salk Inst...-like pore structures formed from scratch, and ins...s discovery adds to the picture of how a cell divi...
Other Biology News:How nerve cells stay in shape 2How nerve cells stay in shape 3Study finds evolution doesn't always favor bigger animals 2Study finds evolution doesn't always favor bigger animals 3Honeybee decision-making ability rivals any department committee 2Honeybee decision-making ability rivals any department committee 3Researchers solve mystery of how nuclear pores duplicate before cell division 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum.
...EnzChek Pyrophosphate Detection Kit,provides a fas...ethod for measuring the inorganic pyrophosphate (P..., such as DNA and,RNA polymerizations, cyclic AMP ...enzymatic activation of fatty acids to,form their ...
...ose Gel-Digesting Preparation contains a unique &b...RE for simple, quantitative recovery of intact DNA... following electrophoresis in TAE, TBE, MOPS, or p... in the TAE, TBE, MOPS, and phosphate electrophore...
Request Info
Biology Products: